Novel bacteriophage having pathogen Salmonella Entritidisspecific antibacterial activity and use thereof
The present invention relates to a novel bacteriophage KFS-SE2 (KCTC 13464BP) showing killing ability specific to pathogenic Salmonella enteritidis, and an antibacterial composition comprising the same. In addition, the present invention relates to a method for variously utilizing the bacteriophage...
Saved in:
Main Authors | , , , , |
---|---|
Format | Patent |
Language | English Korean |
Published |
24.03.2020
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention relates to a novel bacteriophage KFS-SE2 (KCTC 13464BP) showing killing ability specific to pathogenic Salmonella enteritidis, and an antibacterial composition comprising the same. In addition, the present invention relates to a method for variously utilizing the bacteriophage or the antibacterial composition in a composition for preventing or treating infectious diseases, antibiotics, disinfectants, etc.
본 발명은 병원성 살모넬라 엔테리티디스균 특이적인 사멸능을 나타내는 신규 박테리오파지 및 이를 포함하는 항균 조성물에 관한 것이다. 또한 본 발명은 상기 박테리오파지 또는 상기 항균 조성물을 이용하여 감염성 질병 예방 또는 치료용 조성물, 항생제, 소독제 등 다양하게 활용하는 방법에 관한 것이다. |
---|---|
Bibliography: | Application Number: KR20180110221 |